Shares of other companies:
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
Apple’s Technical Climb To $240 By Year-End
April 15, 2024
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
EYPT Stock News and Mentions of EyePoint Pharmaceuticals, Inc. Stocktwits
Updated: April 18, 2024 (13:16)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where EyePoint Pharmaceuticals Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of EyePoint Pharmaceuticals, Inc. (EYPT).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the EyePoint Pharmaceuticals stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of EyePoint Pharmaceuticals, Inc. (EYPT)
April 2, 2024 (11:00) / "GlobeNewswire" (by EyePoint Pharmaceuticals)
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
- Charles Wykoff, M.D., Ph.D. joins Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board ...
In Article Trend: Somewhat-Bullish
March 18, 2024 (11:00) / "Benzinga" (by Globe Newswire)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - EyePoint Pharmaceuticals ( NASDAQ:EYPT )
WATERTOWN, Mass., March 18, 2024 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc.
In Article Trend: Somewhat-Bullish
March 4, 2024 (15:40) / "Benzinga" (by Avi Kapoor)
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday - Tesla ( NASDAQ:TSLA ) , New York Community ( NYSE:NYCB )
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. TSLA fell during Monday's session after the company reportedly saw a decline in February China sales.
In Article Trend: Somewhat-Bearish
February 29, 2024 (15:00) / "Zacks Commentary" (by Zacks Equity Research)
Will EyePoint Pharmaceuticals ( EYPT ) Report Negative Q4 Earnings? What You Should Know
EyePoint Pharmaceuticals (EYPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In Article Trend: Neutral
February 29, 2024 (14:05) / "Zacks Commentary" (by Zacks Equity Research)
Vericel Corporation ( VCEL ) Q4 Earnings Beat Estimates
Vericel Corporation (VCEL) delivered earnings and revenue surprises of 44.44% and 0%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
February 29, 2024 (13:50) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why Momentum in EyePoint Pharmaceuticals ( EYPT ) Should Keep going
EyePoint Pharmaceuticals (EYPT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
In Article Trend: Bullish
February 27, 2024 (12:00) / "Benzinga" (by Globe Newswire)
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - EyePoint Pharmaceuticals ( NASDAQ:EYPT )
WATERTOWN, Mass., Feb. 27, 2024 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc. EYPT, a company committed to developing and commercializing therapeutics to help improve the lives of patients with retinal diseases, today announced that Company management will participate at the following ...
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
Rite Aid Corp. (RAD)
Aridis Pharmaceuticals, Inc. (ARDS)
OrganiGram Holdings Inc. (OGI)
Adagio Therapeutics, Inc. (ADGI)
Aurinia Pharmaceuticals Inc. (AUPH)
Teladoc Health, Inc. (TDOC)
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Zomedica Corp. (ZOM)
Pfizer Inc. (PFE)
Aptevo Therapeutics Inc. (APVO)
This website uses cookies to ensure you get the best experience on our website